Religare Enterprises Fact Sheet, Religare Enterprises Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Religare Enterprises Fact Sheet    (RELIG)

Here is the latest financial fact sheet of Religare Enterprises. For more details, see the Religare Enterprises quarterly results and Religare Enterprises share price and chart. For a sector overview, read our finance sector report.

RELIGARE ENT. Price History

Price Rs 45.6
Mkt Cap Rs m 8,132
Vol '000 119.3
P/E X -6.0
P/CF X -0.6
EPS (TTM) Rs -7.6
% ch % 4.8
No. of shares m 178.33
% ch week % -2.0
% ch 1-mth % 41.4
% ch 12-mth % 34.5
52 week H/L Rs 48.9/17.1
(As on Oct 22, 2019 02:41:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

RELIGARE ENT. Financials

No. of Mths
Year Ending
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
5-Yr Chart
Click to enlarge
RELIGARE ENT. EQUITY SHARE DATA
High Rs374412395295238 
Low Rs25029125620934 
Sales per share (Unadj.) Rs223.5201.9218.0184.1126.2 
Earnings per share (Unadj.) Rs-4.67.6-2.3-8.5-58.2 
Diluted earnings per shareRs-3.98.6-2.7-9.8-66.9 
Cash flow per share (Unadj.) Rs-2.49.4-0.6-7.0-56.3 
Dividends per share (Unadj.) Rs03.30000 
Adj. dividends per shareRs0.003.760.000.000.00 
Dividend yield (eoy) %00.9000 
Book value per share (Unadj.) Rs209.3192.2190.0134.382.2 
Adj. book value per shareRs175.6219.2216.6154.394.5 
Shares outstanding (eoy) m149.61203.33203.33204.83204.95 
Bonus/Rights/Conversions  ESOP---- 
Price / Sales ratio x1.41.71.51.41.1 
Avg P/E ratio x-67.446.4-138.9-29.6-2.3 
P/CF ratio (eoy) x-132.537.5-561.0-36.0-2.4 
Price / Book Value ratio x1.51.81.71.91.7 
Dividend payout %043.6000 
Avg Mkt Cap Rs m46,70171,43066,18451,60727,863 
No. of employees `0005.9NANANANA 
Total wages/salary Rs m6,4487,9989,3366,4504,984 
Avg. sales/employee Rs Th5,683.8NMNM9,429,400.0760,811.8 
Avg. wages/employee Rs Th1,096.0NMNM1,612,475.0146,573.5 
Avg. net profit/employee Rs Th-117.8NMNM-435,700.0-350,735.3 
RELIGARE ENT. INCOME DATA
Net Sales Rs m33,43841,04644,31837,71825,868 
Other income Rs m1,2798287096931,064 
Total revenues Rs m34,71741,87445,02638,41026,932 
Gross profit Rs m17,48520,91423,72321,035-3,856 
Depreciation Rs m341369359310376 
Interest Rs m15,79316,52118,72118,36312,610 
Profit before tax Rs m2,6314,8525,3513,055-15,779 
Minority Interest Rs m-963-1,675-1,085-5071,579 
Prior Period Items Rs m436-20 
Extraordinary Inc (Exp) Rs m-8060-2,533-4,4190 
Tax Rs m1,5591,6422,215-130-2,274 
Profit after tax Rs m-6931,538-477-1,743-11,925 
Gross profit margin %52.351.053.555.8-14.9 
Effective tax rate %59.233.841.4-4.314.4 
Net profit margin %-2.13.7-1.1-4.6-46.1 
RELIGARE ENT. BALANCE SHEET DATA
Current assets Rs m91,847103,02994,95790,53476,160 
Current liabilities Rs m88,107102,008103,03680,91272,751 
Net working cap to sales %11.22.5-18.225.513.2 
Current ratio x1.01.00.91.11.0 
Inventory Days Days446500 
Debtors Days Days5352385940 
Net fixed assets Rs m19,92721,32217,89012,48915,041 
Share capital Rs m1,4962,0332,0332,0482,050 
"Free" reserves Rs m28,48935,19836,59525,46914,797 
Net worth Rs m31,31639,08838,62927,51716,846 
Long term debt Rs m66,22486,883118,58389,16658,287 
Total assets Rs m211,252254,390274,293210,378158,762 
Interest coverage x1.21.31.31.2-0.3 
Debt to equity ratio x2.12.23.13.23.5 
Sales to assets ratio x0.20.20.20.20.2 
Return on assets %7.17.16.77.90.4 
Return on equity %-2.23.9-1.2-6.3-70.8 
Return on capital %17.115.613.014.1-2.1 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m00000 
Fx outflow Rs m808112312 
Net fx Rs m-80-81-12-3-12 
RELIGARE ENT. CASH FLOW
From Operations Rs m 16,344 -7,057 -21,540 58,706 57,227 
From Investments Rs m -4,082 -6,169 5,149 23,178 -4,220 
From Financial Activity Rs m -14,003 10,939 18,531 -76,960 -63,772 
Net Cashflow Rs m -1,741 -2,287 1,978 3,238 -10,769 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 50.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.9%
FIIs 15.3%
ADR/GDR 0.0%
Free float 32.9%
Shareholders 26,518
Pledged promoter(s) holding 68.3%
 

Company Information

REGD OFF D-3, P3B, District Centre, Saket, New Delhi - 110 017
E-MAIL investorservices@religare.com WEB www.religare.com
TELEPHONE (011) 3912 5000 FAX (011) 3912 6117
SECTOR MISCELLANEOUS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Price Waterhouse
CHM: Sunil Godhwani (MD) COMP SEC: Mohit Maheshwari YEAR OF INC: 1984 BSE CODE: 532915 FV (Rs): 10 DIV YIELD (%): -

Read: RELIGARE ENT. 2017-18 Annual Report Analysis

More Miscellaneous Company Fact Sheets:   POWER FINANCE CORPORATION  MAGMA FINCORP  IFCI  RURAL ELECTRIFICATION  M&M FINANCIAL SERVICES  

Compare RELIGARE ENT. With:   POWER FINANCE CORPORATION  MAGMA FINCORP  IFCI  RURAL ELECTRIFICATION  M&M FINANCIAL SERVICES  



Today's Market

Indian Indices Trade on a Volatile Note; Healthcare and Banking Stocks Witness Buying(12:30 pm)

Share markets in India are presently trading marginally higher. Sectoral indices are trading mixed with stocks in the metal sector and IT sector.

Views on news

RELIGARE ENT. Announces Quarterly Results (3QFY19); Net Profit Up 75.2% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, RELIGARE ENT. has posted a net profit of Rs 103 m (up 75.2% YoY). Sales on the other hand came in at Rs 8 m (down 90.1% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

RELIGARE ENT. 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of RELIGARE ENT. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of RELIGARE ENT.. Also includes updates on the valuation of RELIGARE ENT..

RELIGARE ENT. Announces Quarterly Results (2QFY19); Net Profit Up 57.9% (Quarterly Result Update)

Nov 29, 2018 | Updated on Nov 29, 2018

For the quarter ended September 2018, RELIGARE ENT. has posted a net profit of Rs 128 m (up 57.9% YoY). Sales on the other hand came in at Rs 13 m (down 50.7% YoY). Read on for a complete analysis of RELIGARE ENT.'s quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK RELIGARE ENT.

  • Track your investment in RELIGARE ENT. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON RELIGARE ENT.

RELIGARE ENT. 8-QTR ANALYSIS

COMPARE RELIGARE ENT. WITH

MARKET STATS